Eawsakul Komgrit, Chinavinijkul Panarin, Saeeng Rungnapha, Chairoungdua Arthit, Tuchinda Patoomratana, Nasongkla Norased
Department of Biomedical Engineering, Faculty of Engineering, Mahidol University.
Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Mahidol University.
Chem Pharm Bull (Tokyo). 2017;65(6):530-537. doi: 10.1248/cpb.c16-00871.
RSPP050 (AG50) is one of the semi-synthetic andrographolide that is isolated from Andrographis paniculata NEES (Acanthaceae). The anti-proliferation effects of AG50 against cholangiocarcinoma (HuCCT1) were displayed high cytotoxicity. Unfortunately, poor water solubility of AG50 limited its clinical applications. This study aimed to increase the concentration of AG50 in water and drug loading and release study in phosphate-buffered saline (PBS) in the absence/presence of pig liver esterase enzyme. Cytotoxicity of AG50-loaded polymeric micelles was evaluated against HuCCT1. AG50 loaded micelles were prepared by film sonication and encapsulated by polymers including poly(ethylene glycol)-b-poly(ε-caprolactone) (PEG-b-PCL) or poly(ethylene glycol)-b-poly(D,L-lactide) (PEG-b-PLA). Micelle properties were characterized such as solubility, drug loading, drug release and in vitro cytotoxicity against HuCTT1. AG50 was successfully loaded into both types of polymeric micelles. The best drug-polymer (D/P) ratio was 1 : 9. AG50/PCL and AG50/PLA-micelles had small particle size (36.4±5.1, 49.0±2.7 nm, respectively) and high yield (58.2±1.8, 58.8±2.9, respectively). AG50/PLA-micelles (IC=2.42 µg/mL) showed higher cytotoxicity against HuCCT1 than AG50/PCL-micelles (IC=4.40 µg/mL) due to the higher amount of AG50 released. Nanoencapsulation of AG50 could provide a promising development in clinical use for cholangiocarcinoma treatment.
RSPP050(AG50)是一种从穿心莲(爵床科)中分离得到的半合成穿心莲内酯。AG50对胆管癌(HuCCT1)的抗增殖作用表现出高细胞毒性。不幸的是,AG50的水溶性差限制了其临床应用。本研究旨在提高AG50在水中的浓度,并在不存在/存在猪肝酯酶的情况下,在磷酸盐缓冲盐水(PBS)中进行载药和释药研究。评估了载有AG50的聚合物胶束对HuCCT1的细胞毒性。通过薄膜超声法制备载有AG50的胶束,并用聚(乙二醇)-b-聚(ε-己内酯)(PEG-b-PCL)或聚(乙二醇)-b-聚(D,L-丙交酯)(PEG-b-PLA)等聚合物进行包封。对胶束的性质进行了表征,如溶解度、载药量、药物释放以及对HuCTT1的体外细胞毒性。AG50成功地载入了两种类型的聚合物胶束中。最佳药物-聚合物(D/P)比例为1∶9。AG50/PCL和AG50/PLA胶束粒径小(分别为36.4±5.1、49.0±2.7 nm),产率高(分别为58.2±1.8、58.8±2.9)。由于释放的AG50量较高,AG50/PLA胶束(IC = 2.42 μg/mL)对HuCCT1的细胞毒性高于AG50/PCL胶束(IC = 4.40 μg/mL)。AG50的纳米包封可为胆管癌治疗的临床应用提供有前景的发展方向。